Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical Trials
优化肝脏安全性风险评估:将机制模型和血清生物标志物应用于西美格列明α(GGF2)临床试验
期刊:Clinical Pharmacology & Therapeutics
影响因子:5.5
doi:10.1002/cpt.711
Longo, D M; Generaux, G T; Howell, B A; Siler, S Q; Antoine, D J; Button, D; Caggiano, A; Eisen, A; Iaci, J; Stanulis, R; Parry, T; Mosedale, M; Watkins, P B